Athena Company Profile

✉ Email this page to a colleague

ATHENA has three approved drugs.

There are eight US patents protecting ATHENA drugs.

There are twenty patent family members on ATHENA drugs in fourteen countries and two supplementary protection certificates in two countries.

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Athena	FIBRICOR	fenofibric acid	TABLET;ORAL	022418-001	Aug 14, 2009		DISCN	Yes	No	7,741,373	⤷ Sign Up				⤷ Sign Up
Athena	NEXICLON XR	clonidine	TABLET, EXTENDED RELEASE;ORAL	022500-002	Dec 3, 2009		DISCN	No	No	8,623,409	⤷ Sign Up	Y			⤷ Sign Up
Athena	FIBRICOR	fenofibric acid	TABLET;ORAL	022418-001	Aug 14, 2009		DISCN	Yes	No	7,741,374	⤷ Sign Up				⤷ Sign Up
Athena	QDOLO	tramadol hydrochloride	SOLUTION;ORAL	214044-001	Sep 1, 2020		RX	Yes	Yes	11,752,103	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0566709	C300152	Netherlands	⤷ Sign Up	PRODUCT NAME: TRAMADOLI HYDROCHLORIDUM EN PARACETAMOLUM; NAT. REGISTRATION NO/DATE: RVG 28113 20030115; FIRST REGISTRATION: 359 228-3 2002050405
0566709	SPC/GB04/012	United Kingdom	⤷ Sign Up	PRODUCT NAME: TRAMADOL HYDROCHLORIDE, PARACETAMOL; REGISTERED: FR NL 25970 20020405; UK PL 00242/0384 20030925
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.